FDA Enforcement
Class II
Terminated
"Pressure Injectable Jugular Axillo-Subclavian Central Catheter (JACC) Product" The CG+ Arrow JACC powered by Arrow VPS Stylet permits venous access to the central circulation through a central vein. The VPS Stylet, used with the VPS Console, quickly and accurately guides the central catheters to the desired location which is the lower third of the SVC or at the cavo-atrial junction
Recall: Z-2292-2017
·
Reported June 14, 2017
Enforcement
- Recall Number
- Z-2292-2017
- Event ID
- 76937
- Classification
- Class II
- Status
- Terminated
- Product Type
- Devices
- Firm
- Arrow International Inc
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- June 14, 2017
- Initiation Date
- March 20, 2017
- Classification Date
- June 6, 2017
- Termination Date
- December 18, 2018
- Address
- 2400 Bernville Rd, N/A, Reading, PA, 19605-9607, United States
Description
"Pressure Injectable Jugular Axillo-Subclavian Central Catheter (JACC) Product" The CG+ Arrow JACC powered by Arrow VPS Stylet permits venous access to the central circulation through a central vein. The VPS Stylet, used with the VPS Console, quickly and accurately guides the central catheters to the desired location which is the lower third of the SVC or at the cavo-atrial junction
Reason
Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.
Code Info
Material number CDC-41541-JX1A
Distribution
Nationwide Distribution
Quantity
unknown-firm reports total devices distributed 43,394